The U.S. Food and Drug Administration approved the pill version of Wegovy on December 22, marking the first FDA-approved ...

Wegovy has announced that it has developed a pill version of the wildly popular weight loss drug. The Wegovy website was touting the pill on January 5. “The first and only FDA-approved GLP-1 pill to ...

Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments ...

Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction ...

One man is stocking up on cupping kits for his home spa. In Seattle, a fitness buff is paying for yoga classes, ski passes ...

As rules tighten worldwide, more people are pursuing dual citizenship as a form of mobility, opportunity and insurance in an ...

Nvidia’s new lineup of open-source AI models is headlined by Alpamayo 1 (pictured), a so-called VLA, or ...

Dr. Shereene Idriss launched her namesake brand, Dr. Idriss Skincare, in 2022. Here, read about the products she considers ...

Report OverviewThe global botulinum toxin market is entering a phase of sustained expansion, with growth propelled by rising demand in both aesthetic and therapeutic domains. As a neurotoxin derived ...

Pallavi Gupta writes Pallavi Gupta writes that women choose predictable welfare as rational risk management, not populism ...

Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics ("Protagonist") announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of ...